FDx Advisors Inc. Has $263,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

FDx Advisors Inc. lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 63.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 592 shares of the medical equipment provider’s stock after selling 1,021 shares during the period. FDx Advisors Inc.’s holdings in Intuitive Surgical were worth $263,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Creekmur Asset Management LLC boosted its holdings in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new position in Intuitive Surgical during the second quarter worth about $26,000. Able Wealth Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $28,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 239 shares of Intuitive Surgical stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $416.60, for a total value of $99,567.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,293,799.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, EVP Robert Desantis sold 239 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,293,799.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Insiders sold a total of 51,656 shares of company stock worth $24,700,644 over the last three months. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. The Goldman Sachs Group began coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They set a “buy” rating and a $500.00 price target for the company. Morgan Stanley boosted their target price on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Truist Financial boosted their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research note on Tuesday, July 16th. Finally, Piper Sandler increased their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $476.69 on Friday. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $493.97. The company has a fifty day moving average of $458.20 and a 200-day moving average of $417.34. The company has a market capitalization of $169.08 billion, a P/E ratio of 86.05, a P/E/G ratio of 5.43 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. During the same period last year, the business earned $1.18 earnings per share. The business’s quarterly revenue was up 14.5% on a year-over-year basis. As a group, analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.